MedPath

Improvement of Anxiety Management During a Venous Puncture About Children With a Participatory Entertainment Method

Not Applicable
Completed
Conditions
Anxiety Disorders
Interventions
Procedure: "fabrique à histoire"
Procedure: Usual care
Registration Number
NCT04200196
Lead Sponsor
University Hospital, Brest
Brief Summary

The purpose of this study is to demonstrate an anxiety decrease about children 3 to 6 years during a venous puncture with the "fabrique à histoire".

Detailed Description

The purpose of this study is to demonstrate an anxiety decrease about children 3 to 6 years during a venous puncture with the "fabrique à histoire".

the study will compare the "fabrique à histoire"(Lunii(R)) with the usual care.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
116
Inclusion Criteria
  • Children 3 to 6 years in pediatric emergency needing to venous puncture
  • Oral consent by children
  • Informed and signed consent by tenured of parent authority
  • To have Anaesthetic patch 45 minutes or more before the venous puncture
Exclusion Criteria
  • To have Anaesthetic patch less than 45 minutes before the venous puncture because of necessity to blood test or an other emergency
  • Necessity to analgesic 3 emergency
  • Necessity to MEOPA
  • Minor parents
  • Assessment of anxiety is not possible because of comorbidity
  • Anterior participation to these study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
"Fabrique à histoire""fabrique à histoire"Children 3 to 6 years in pediatric emergency needing to venous puncture and randomized in the "fabrique à histoire (Lunii(R))" arm in addition to the routine anaesthetic cream patch.
Usual careUsual careChildren 3 to 6 years in pediatric emergency needing to venous puncture and randomized in the habitual care arm in addition to the routine anaesthetic cream patch.
Primary Outcome Measures
NameTimeMethod
modified Yale Preoperative Anxiety Scale (mYPAS)through study completion, an average of 2 hours

Evolution of mYPAS (validated anxiety scale with a scale 23,3 (no anxiety) to 100 (max of anxiety) between T0 and T2 (after venipuncture). mYPAS is quoted by an extern observator.

Secondary Outcome Measures
NameTimeMethod
Children face scalethrough study completion, an average of 2 hours

Evolution of Self-assessment of pain with the face scale caused by the venous puncture for children 4 to 6 years between T0 and T2 (after venipuncture)

FLACC Scalethrough study completion, an average of 2 hours

Evolution assessment of pain caused by the venous puncture for children assess by caregivers and measured with FLACC Scale (Face Legs Activity Cry Consolability / 0=no pain and 10=max pain) between T0 and T2 (after venipuncture)

Parent anxiety assessmentthrough study completion, an average of 2 hours

Assessment of anxiety caused by the venous puncture for children assess by parents at T2 with an Analogue and Visual Scale (AVS) 10 levels (0=No anxiety 10=max anxiety)

Parent pain assessmentthrough study completion, an average of 2 hours

Assessment of pain caused by the venous puncture for children assess by parents at T2 with an AVS 10 level (0=No pain 10=max pain)

Number of venous puncture before successthrough study completion, an average of 2 hours

Number of venous puncture tentative(s) before success

Venous puncture successthrough study completion, an average of 2 hours

Success or not (Yes/No) of the venous puncture

Time before venous puncture successthrough study completion, an average of 2 hours

Measure of time spent performing the act before its success

Caregivers feedbackthrough study completion, an average of 2 hours

Assessment of caregivers feedback from the gesture with an AVS 0 (worst feeling) to 10 (best feeling)

Parents feedbackthrough study completion, an average of 2 hours

Assessment of parents feedback from the gesture with an AVS 0 (worst feeling) to 10 (best feeling)

Trial Locations

Locations (1)

CHRU de Brest

🇫🇷

Brest, Finistère, France

© Copyright 2025. All Rights Reserved by MedPath